Rafael Santana Davila, MD, Oncology, Seattle, WA, Seattle Cancer Care Alliance

RafaelSantana DavilaMD

Oncology Seattle, WA

Thoracic Cancer

Associate Professor. University of Washington. Fred Hutchinson Cancer Research Center/ Seattle Cancer Care Alliance

Overview of Dr. Santana Davila

Dr. Rafael Santana Davila is an oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including Seattle Cancer Care Alliance, Seattle Cancer Care Alliance, and University of Washington Medical Center. He received his medical degree from Universidad Anahuac School of Medicine and has been in practice 16 years. Dr. Santana Davila accepts several types of health insurance, listed below. He is one of 157 doctors at Seattle Cancer Care Alliance and one of 140 doctors at University of Washington Medical Center who specialize in Oncology.

Education & Training

  • Medical College of Wisconsin
    Medical College of WisconsinOTHER_TRAINING
  • Mayo School of Graduate Medical Education
    Mayo School of Graduate Medical EducationFELLOWSHIP
  • Mayo Clinic College of MedicineOTHER_TRAINING
  • University of Minnesota
    University of MinnesotaRESIDENCY
  • Universidad Anahuac School of Medicine
    Universidad Anahuac School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2014 - 2021
  • WI State Medical License
    WI State Medical License 2010 - 2015
  • MN State Medical License
    MN State Medical License 2006 - 2011
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Small Grant Program Award Mayo Clinic Department of Oncology, 2009
  • Best Teacher Award Graduating Class of Medical Student University of Minnesota, 2006
  • Join now to see all

Publications & Presentations


Journal Articles

  • Evaluation and management of elderly patients with lung cancer.  
    Gore E, Movsas B, Santana-Davila R, Langer C, Semin Radiat Oncol, 1/1/2012
  • Treatment options for patients with triple-negative breast cancer.  
    Santana-Davila, R. & Perez, E.A., J Hematol Oncol, 1/1/2010
  • Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy.  
    Jatoi, A., Smith EL, Gunderson, HD, Hartgers, ML, Looker SA, Santana-Davila R, McWilliams RR, J Oncol Pract, 1/1/2010
  • Join now to see all


  • Clinicopathological characteristics of subsequent breast cancers in patients with benign breast disease. 
    45th Annual Meeting of the American Society of Clinical Oncology, Orlando, FL - 1/1/2009
  • Deletion 5q in Acute Myeloid Leukemia (AML): a Clinicopathological Description of 79 Cases From a Single Institution. 
    50th Annual Meeting of the American Society of Hematology, San Francisco, CA - 1/1/2008
  • Deletion 5q in WHO- Defined Myeloproliferative Neoplasms: A Clinicopathological Description 
    49th Annual Meeting of the American Society of Hematology, Atlanta, GA - 1/1/2007
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Anthem Blue Access PPO
    Anthem Blue Preferred HMO
    Anthem Blue Preferred Plus POS
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA Open Access
    First Health PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Network Health Plan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
    WEA Trust Preferred Provider Plan - Trust Pref
  • Please verify your coverage with the provider's office directly when scheduling an appointment